Politics of Cancer - malecare.org

Malecare and the New York State Prostate Cancer Coalition Are Victorious and Force the Hand of New York State Governor Andrew Cuomo to Fund $3,000,000 Towards Prostate Cancer Research

Approximately 2 years ago Malecare and the New York State Prostate Coalition began asking questions about where the State of New York was hiding approximately $3,000,000 in funding for prostate cancer research. Each year New York State residents are asked to check off a little box on their state tax return donating an additional dollar [...]

By Malecare|2017-10-19T10:46:55-04:00October 8th, 2015|Advanced Prostate Cancer, Advocacy, Clinical Trials & Research, Financial, Politics of Cancer, Research, Uncategorized|0 Comments

Understanding and Trying to Rectify the Abusive Costs of Our Drugs

I have been relatively quiet about the skyrocketing cost of drugs, but it has now become impossible to remain out of the fray. A Pharmaceutical company recently acquired a drug called Daraprim, the drug treats potentially fatal parasitic infections. After its acquisition the company raised the price of Daraprim by almost 5,0000%. When confronted with [...]

By Malecare|2017-10-19T10:46:55-04:00September 28th, 2015|Advanced Prostate Cancer, Advocacy, Drugs & Treatments, Financial, Insurance, Medical Insurance, Medicare/Medicaid, Politics of Cancer, Survival, Uncategorized|0 Comments

Are You Having Trouble Getting Early Access To Chemotherapy?

During last year’s American Society of Clinical Oncologists (ASCO) Annual Meeting, data was released from the STAMPEDE trial which should change clinical practice around the world. The trial results showed that newly diagnosed men with very aggressive prostate cancer that was still hormone therapy naive (no ADT) would have a very significant survival advantage by [...]

By Malecare|2015-07-21T18:35:53-04:00July 21st, 2015|ADT, Advanced Prostate Cancer, Advocacy, ASCO, Chemotherapy, Clinical Trials & Research, docetaxel, Drugs & Treatments, Hormone Therapy, Politics of Cancer, Survival, taxotere, Uncategorized, United Kingdom - England, Northern Ireland, Scotland & Wales|0 Comments

CDC Funding For Prostate Cancer Saved

The line item for FY 2016 CDC prostate cancer funding of $13,205,000 is restored in both the House and Senate appropriations bills, as authored by their committees. Thanks to the several thousand of you who responded to Malecare's call to action and wrote emails and letters to the Congressional House and Senate Budget Committee. Since both [...]

By Malecare|2015-06-23T20:32:34-04:00June 23rd, 2015|Advanced Prostate Cancer, Advocacy, CDC, General Information, Governmental and Professional Organizations, Politics of Cancer, Uncategorized|0 Comments

A Step Towards Understanding How To Get A Fair Value For The Dollars Spent For Advanced Prostate Cancer Treatment

In the treatment of prostate cancer the first very expensive drug we had that was FDA approved was Provenge, with an initial cost of $93,000 for a one-month’s treatment protocol. Today, the cost is in excess of $106,000. According to the phase III clinical trial result Provenge extends life by a median of 4.1 months, [...]

By Malecare|2020-02-04T11:56:10-05:00June 23rd, 2015|Advanced Prostate Cancer, advanced prostate cancer support group, ASCO, Drugs & Treatments, Financial, Insurance, Medical Insurance, Medicare/Medicaid, Politics of Cancer, survival, survivorship, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments